About this trial
Fentanyl and esketamine are both standard of care for treatment of acute severe traumatic pain in the prehospital setting in the Netherlands. However, it is not known whether they are equally effective and safe. It is also not known whether intranasal (IN) administration of fentanyl or esketamine is equally effective and safe as intravenous (IV) administration.
The FORE-PAIN trial is a double-blind multi-arm randomized non-inferiority trial comparing Fentanyl IN, esketamine IV and esketamine IN (intervention arms) to fentanyl IV (comparator arm) for prehospital management of traumatic pain. The investigators hypothesize that all intervention arms provide analgesia that is non-inferior to the comparator arm, and that all study arms are equally safe.
Eligibility criteria
Qualifiers
age ≥ 18 years
pain has been caused by a trauma (any trauma mechanism) that occurred on the same day
Emergency Medical Services personnel determines that administration of a strong opioid or esketamine for analgesia is required
patient will be transported to a hospital
Disqualifiers
(estimated) weight <40 or >100 kg
subject does not understand Dutch or English
inability to report pain score
inability to give IN or IV medication
Trial design
Treatments tested in this trial
- Fentanyl Citrate
- Esketamine
Treatment groups
Sponsors and collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead sponsor
Stichting ZiektekostenVerzekering Krijgsmacht
Collaborator
Ambulance Amsterdam
Collaborator